JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB201804

DyLight® 680 Conjugation Kit (Fast) - Lightning-Link®

Be the first to review this product! Submit a review

|

(4 Publications)

DyLight® 680 Conjugation Kit (Fast) - Lightning-Link® (ab201804) offers several standout features:

- Rapid Conjugation: achieve DyLight® 680 labeling in under 20 minutes with just 30 seconds of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: suitable for conjugating antibodies, proteins, and peptides. DyLight® 680-labeled antibodies can be used immediately in applications such as Western blot, ELISA, and Immunohistochemistry (IHC) without further purification.
2 Images
Schematic Diagram - DyLight® 680 Conjugation Kit (Fast) - Lightning-Link® (AB201804)
  • Schematic Diagram

Supplier Data

This illustration demonstrates a general procedure of how the Lightning-Link®(Fast) labeling technology enables the direct labeling of antibodies or proteins.

Simply pipette your antibody or biomolecule of choice into the vial of a lyophilized mixture containing the label of interest and incubate for just 15 minutes. Please see the ab201804 protocol booklet for more details.

Learn more about our Lightning-Link® conjugation kits here

Flow Cytometry - DyLight® 680 Conjugation Kit (Fast) - Lightning-Link® (AB201804)
  • Flow Cyt

PubMed

Heidepriem, Jasmin, et al used DyLight® 680 Conjugation Kit (Fast) - Lightning-Link® (ab201804) as part of examining the Ebola virus (EBOV). They used the kit to conjugate DyLight™ 680 to anti-HA-peptide antibody for use in peptide microarray.
Peptide microarray siplaying fluorescence from secondary antibodies as a heat map (top : IgG response, bottom : IgM response). The EBOV surface glycoprotein (GP) (676 AA) was mapped as 662 spots of 15-mer peptides with a lateral shift of one AA. Sera from seven recombinant vesicular stomatitisvirus-Zaire ebolavirus-GP (rVSV-ZEBOV-GP) vaccines (numbered) and one EVD survivor were analyzed on separatemicroarrays. The vaccines are listed with the day of serum collection after vaccination. The defined epitopes are named by their origin from vaccines(V, in orange), survivor (S, in red) or both (SV, in orange and red)

Image from Heidepriem, Jasmin, et al. Biotechnol J., 15(9): e2000069. doi: 10.1002/biot.202000069. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Key facts

Product details

DyLight® 680 Conjugation Kit / DyLight® 680 Labeling Kit ab201804 uses a simple and quick process for DyLight® 680 labeling / conjugation of antibodies. It can also be used to conjugate other proteins or peptides. Learn about our antibody labeling kits and their advantages.

This product is manufactured by Expedeon, an Abcam company. See the table below to match Abcam kit size against Expedeon product code.

To conjugate an antibody to DyLight® 680 using this kit:
- add modifier to antibody and incubate for 15 mins
- add quencher and incubate for 5 mins
The DyLight® 680 conjugated antibody can be used immediately in WB, ELISA, IHC etc. No further purification is required and 100% of the antibody is recovered for use.

Learn about buffer compatibility below; for incompatible buffers and low antibody concentrations, use our rapid antibody purification and concentration kits. Use the FAQ to learn more about the technology, or about conjugating other proteins and peptides to DyLight® 680.

Custom size conjugation kits up to 100 mg are available on demand. Please contact us to discuss your requirements.

This product is manufactured by Expedeon, an Abcam company, and was previously called Lightning-Link® Rapid DyLight® 680 Labeling Kit. 327-0005 is the same as the 100 μg size. 327-0030 is the same as the 3 x 10 ug size. 327-0010 is the same as the 3 x 100 ug size. 327-0015 is the same as the 1 mg size.

Amount and volume of antibody for conjugation to Dylight® 680

Kit size Recommended
amount of antibody1
Maximum
amount of antibody
Maximum antibody
volume2
3 x 10 μg 3 x 10 μg 3 x 20 μg 3 x 10 μL
100 μg 1 x 100 μg 1 x 200 μg 1 x 100μL
3 x 100 μg 3 x 100 μg 3 x 200 μg 3 x 100 μL
1 mg 1 x 1 mg 1 x 2 mg 1 x 1 mL

1 Using the maximum amount of antibody may result in less labelling per antibody.

2 Ideal antibody concentration is 1mg/ml. 0.5 - 1 mg/ml can be used if the maximum antibody volume is not exceeded. Antibodies > 2 mg/ml or < 0.5 mg/ml should be diluted /concentrated.

Buffer Requirements for Conjugation

Buffer should be pH 6.5-8.5.

Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.

50mM / 0.6% Tris1 0.1% BSA2 50% glycerol
0.1% sodium azide PBS Potassium phosphate
Sodium chloride HEPES Sucrose
Sodium citrate EDTA Trehalose

1 Tris buffered saline is almost always ≤ 50 mM / 0.6%
2 BSA can also interfere with the use of the conjugated antibody in tissue staining.

Incompatible buffer constituents

Thiomerosal Proclin Glycine
Arginine Glutathione DTT

If a constituent of the buffer containing your antibody or protein is not listed above, please contact us.

Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture media are incompatible.

Storing and handling conjugation kits

Lyophilized Lightning-Link® components are hygroscopic.

Kits are intentionally shipped at ambient temperature with silica gel to avoid exposure to moisture. Upon receipt, store the kit frozen and protect from moisture. Before opening the outer container, allow the lyophilized components to reach room temperature to minimize condensation.

DyLight® is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

What's included?

{ "values": { "3x10g": { "sellingSize": "3 x 10 µg", "publicAssetCode":"ab201804-3x10ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201804-CMP03" }, { "size":"3 x 10 µg", "name":"Dylight® 680 Conjugation Mix", "number":"AB201804-CMP01" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201804-CMP02" } ] }, "3x100g": { "sellingSize": "3 x 100 µg", "publicAssetCode":"ab201804-3x100ug", "assetComponentDetails": [ { "size":"3 x 100 µg", "name":"Dylight® 680 Conjugation Mix", "number":"AB201804-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201804-CMP03" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201804-CMP02" } ] }, "1mg": { "sellingSize": "1 mg", "publicAssetCode":"ab201804-1mg", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201804-CMP02" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201804-CMP03" }, { "size":"1 x 1 mg", "name":"Dylight® 680 Conjugation Mix", "number":"AB201804-CMP01" } ] }, "100g": { "sellingSize": "100 µg", "publicAssetCode":"ab201804-100ug", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Dylight® 680 Conjugation Mix", "number":"AB201804-CMP01", "productcode":"" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201804-CMP02", "productcode":"" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201804-CMP03", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Ambient - Cannot Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Target data

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Cell reports 34:108863 PubMed33691089

2021

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.

Applications

Unspecified application

Species

Unspecified reactive species

Elizabeth A Thompson,Katherine Cascino,Alvaro A Ordonez,Weiqiang Zhou,Ajay Vaghasia,Anne Hamacher-Brady,Nathan R Brady,Im-Hong Sun,Rulin Wang,Avi Z Rosenberg,Michael Delannoy,Richard Rothman,Katherine Fenstermacher,Lauren Sauer,Kathyrn Shaw-Saliba,Evan M Bloch,Andrew D Redd,Aaron A R Tobian,Maureen Horton,Kellie Smith,Andrew Pekosz,Franco R D'Alessio,Srinivasan Yegnasubramanian,Hongkai Ji,Andrea L Cox,Jonathan D Powell

medRxiv : the preprint server for health sciences : PubMed32935120

2020

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.

Applications

Unspecified application

Species

Unspecified reactive species

Elizabeth A Thompson,Katherine Cascino,Alvaro A Ordonez,Weiqiang Zhou,Ajay Vaghasia,Anne Hamacher-Brady,Nathan R Brady,Im-Hong Sun,Rulin Wang,Avi Z Rosenberg,Michael Delannoy,Richard Rothman,Katherine Fenstermacher,Lauren Sauer,Kathyrn Shaw-Saliba,Evan M Bloch,Andrew D Redd,Aaron Ar Tobian,Maureen Horton,Kellie Smith,Andrew Pekosz,Franco R D'Alessio,Srinivasan Yegnasubramanian,Hongkai Ji,Andrea L Cox,Jonathan D Powell

Biotechnology journal 15:e2000069 PubMed32463974

2020

Epitopes of Naturally Acquired and Vaccine-Induced Anti-Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution.

Applications

Unspecified application

Species

Unspecified reactive species

Jasmin Heidepriem,Verena Krähling,Christine Dahlke,Timo Wolf,Florian Klein,Marylyn M Addo,Stephan Becker,Felix F Loeffler

Molecular & cellular proteomics : MCP 18:642-656 PubMed30630936

2019

High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas Jaenisch,Kirsten Heiss,Nico Fischer,Carolin Geiger,F Ralf Bischoff,Gerhard Moldenhauer,Leszek Rychlewski,Ali Sié,Boubacar Coulibaly,Peter H Seeberger,Lucjan S Wyrwicz,Frank Breitling,Felix F Loeffler
View all publications
websiteProtocolBooklet
en
websiteProtocolBooklet
zh

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com